MENLO PARK, Calif., Jan. 13, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today celebrated long-read sequencing being named Nature Methods’ “Method of the Year 2022.” Nature Methods had recognized...| PacBio
In the recent precisionFDA Truth Challenge V2, which evaluated methods for variant calling in human genomes, approaches that use PacBio HiFi reads delivered the highest precision and recall in all categories: genome-wide, specifically in difficult-to-map regions, and in the major histocompatibility complex.| PacBio
Explore how HiFi whole-genome sequencing outshines exome and short-read methods in comprehensive variant detection.| PacBio
A new preprint from multiple leading research groups proposes that the time is now to apply long-read sequencing in population-scale projects.| PacBio
Software tools for long-read Sequel II/IIe and Revio systems designed to set up and monitor HiFi sequencing runs, review performance metrics, analyze, visualize, and annotate sequencing data.| PacBio
PacBio HiFi sequencing has exceptionally accurate long reads and unbiased coverage required to provide comprehensive whole genome sequencing.| PacBio
PacBio’s newest long-read sequencer makes the power of long-read sequencing more affordable, at scale.| PacBio
